clopidogrel has been researched along with Adenoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Blackburn, SL; Ciavarra, B; Guttenberg, KB; Kole, MJ; Li, W; McIntyre, T; Yao, W | 1 |
| Edogawa, S; Harada, S; Higuchi, K; Kojima, Y; Ota, K; Takeuchi, T; Tokioka, S; Umegaki, E | 1 |
| Ogawa, Y; Tominaga, T | 1 |
3 other study(ies) available for clopidogrel and Adenoma
| Article | Year |
|---|---|
Antiplatelet and anticoagulation therapy and the risk of pituitary apoplexy in pituitary adenoma patients.
Topics: Adenoma; Anticoagulants; Clopidogrel; Hemorrhage; Hormones; Humans; Male; Pituitary Apoplexy; Pituitary Neoplasms; Retrospective Studies; Stroke | 2023 |
The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection.
Topics: Adenoma; Aged; Anti-Ulcer Agents; Anticoagulants; Aspirin; Carcinoma; Case-Control Studies; Clopidogrel; Dissection; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Stomach Diseases; Stomach Neoplasms; Stomach Ulcer; Thienopyridines; Ticlopidine; Warfarin | 2013 |
Sellar and parasellar tumor removal without discontinuing antithrombotic therapy.
Topics: Adenoma; Aged; Aspirin; Central Nervous System Cysts; Clopidogrel; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Postoperative Period; Ticlopidine; Treatment Outcome | 2015 |